期刊
CLINICAL PHARMACOLOGY & THERAPEUTICS
卷 89, 期 5, 页码 750-753出版社
WILEY
DOI: 10.1038/clpt.2011.1
关键词
-
资金
- Leona M. and Harry B. Helmsley Charitable Trust
Induced pluripotent stem (iPS) cells, with their ability to differentiate into every cell type of the body, represent a perfect source for cell-replacement therapies in type 1 diabetes (T1D). Hence, there is a need to optimize the differentiation protocols to generate fully glucose-responsive and mature cells. In addition, the use of iPS cells could make possible the generation of patient-specific disease models that could further our understanding of the root cause of autoimmune diabetes.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据